Compare Stocks → A new way to collect income from stocks (From DTI) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison NASDAQ:ALTNYSE:ASG Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeALTAltimmune$7.08-6.5%$9.35$2.09▼$14.84$536.68M0.053.67 million shs2.20 million shsASGLiberty All-Star Growth Fund$5.14-0.6%$5.37$4.47▼$5.71$300.50M1.33218,740 shs89,347 shsThe Best High-Yield Dividend Stocks for 2024Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceALTAltimmune-6.47%+0.57%-17.00%-23.71%+35.37%ASGLiberty All-Star Growth Fund-0.48%-0.87%-5.43%-1.63%+3.11%Just Released: Insider's Secret to Trading Options (Ad)This Surprisingly Simple Formula Can Double Your Money Collecting Consistent Profits From The Stock Market Is More Accessible Than You Think A small group of individuals are using a legitimate yet rarely discussed strategy to generate income from the stock market. They're NOT day traders. And they're NOT Wall Street suits either. I'm talking about normal "working stiffs" and retirees generating steady income from a source that 99% of investors completely overlook. This overlooked income source can be yours today.Yes! Show Me This StrategyMarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationALTAltimmune1.6346 of 5 stars3.32.00.00.03.21.70.0ASGLiberty All-Star Growth FundN/AN/AN/AN/AN/AN/AN/AN/AAnalyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceALTAltimmune2.67Moderate Buy$15.00111.86% UpsideASGLiberty All-Star Growth FundN/AN/AN/AN/ACurrent Analyst RatingsLatest ADR, ALT, and ASG Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails4/1/2024ALTAltimmuneHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$15.00 ➝ $12.003/28/2024ALTAltimmuneB. RileySubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$20.002/13/2024ALTAltimmuneB. RileySubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$20.00(Data available from 4/25/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookALTAltimmune$430K1,167.21N/AN/A$2.75 per share2.57ASGLiberty All-Star Growth FundN/AN/AN/AN/AN/AN/AProfitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateALTAltimmune-$88.45M-$1.65N/AN/AN/A-20,780.75%-44.77%-40.72%5/9/2024 (Estimated)ASGLiberty All-Star Growth FundN/AN/A0.00∞N/AN/AN/AN/AN/ALatest ADR, ALT, and ASG EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails3/27/2024Q4 2023ALTAltimmune-$0.35-$0.33+$0.02-$0.12N/A$0.04 millionDividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthALTAltimmuneN/AN/AN/AN/AN/AASGLiberty All-Star Growth Fund$0.448.57%-5.53%N/A1 YearsLatest ADR, ALT, and ASG DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date4/8/2024ASGLiberty All-Star Growth Fundquarterly$0.127.9%4/18/20244/19/20246/3/2024(Data available from 1/1/2013 forward)DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioALTAltimmuneN/A17.2617.26ASGLiberty All-Star Growth FundN/AN/AN/AOwnershipInstitutional OwnershipCompanyInstitutional OwnershipALTAltimmune78.05%ASGLiberty All-Star Growth Fund21.62%Insider OwnershipCompanyInsider OwnershipALTAltimmune4.10%ASGLiberty All-Star Growth Fund0.32%MiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableALTAltimmune5970.89 million67.99 millionOptionableASGLiberty All-Star Growth FundN/A58.24 million58.05 millionNot OptionableADR, ALT, and ASG HeadlinesSourceHeadlineLiberty All-Star Growth Fund, Inc. (ASG)finance.yahoo.com - April 18 at 8:20 PMLiberty All-Star Growth Fund, Inc. (NYSE:ASG) Short Interest Updatemarketbeat.com - April 15 at 9:45 AMLiberty All-Star® Growth Fund, Inc. March 2024 Monthly Updateprnewswire.com - April 12 at 7:53 PMLiberty All-Star Growth Fund, Inc. (NYSE:ASG) Plans Quarterly Dividend of $0.12marketbeat.com - April 9 at 4:50 PMLiberty All-Star® Growth Fund, Inc. Declares Distributionprnewswire.com - April 8 at 1:30 PMShort Interest in Liberty All-Star Growth Fund, Inc. (NYSE:ASG) Declines By 8.2%marketbeat.com - April 2 at 10:12 PMThis Media-Driven Panic Has Put Our Favorite 7%+ Yielders on Salemarketbeat.com - March 31 at 10:03 PMInsider Buying: Liberty All-Star Growth Fund, Inc. (NYSE:ASG) Insider Acquires 3,500 Shares of Stockinsidertrades.com - March 27 at 5:41 AMLiberty All-Star Growth Fund, Inc. (NYSE:ASG) Insider Acquires $19,075.00 in Stockmarketbeat.com - March 26 at 9:18 PMLiberty All-Star® Growth Fund, Inc. February 2024 Monthly Updateprnewswire.com - March 13 at 1:06 PMMaureen K. Usifer Acquires 2,800 Shares of Liberty All-Star Growth Fund, Inc. (NYSE:ASG) Stockinsidertrades.com - March 12 at 7:50 PMLiberty All-Star® Growth Fund, Inc. January 2024 Monthly Updatefinance.yahoo.com - February 13 at 6:12 PMLiberty All-Star® Growth Fund, Inc. January 2024 Monthly Updateprnewswire.com - February 13 at 5:57 PMLiberty All-Star Growth Fund Inc.thestreet.com - February 10 at 1:58 PMLiberty All-Star® Growth Fund, Inc. December 2023 Monthly Updatefinance.yahoo.com - January 12 at 7:06 PMLiberty All-Star® Growth Fund, Inc. November 2023 Monthly Updatefinance.yahoo.com - December 13 at 6:09 PMASG: A Great Diversifier In Today's Top-Heavy Marketseekingalpha.com - December 13 at 8:08 AMWednesday Is Your Last Chance To Buy Liberty All Star Growth Before The Dividend Payoutbenzinga.com - November 13 at 3:12 PMLiberty All-Star® Growth Fund, Inc. October 2023 Monthly Updatefinance.yahoo.com - November 13 at 3:12 PMLiberty All-Star Growth dividend declines by 9.1% to $0.10msn.com - November 6 at 3:03 PMLiberty All-Star® Growth Fund, Inc. September 2023 Monthly Updatefinance.yahoo.com - October 12 at 7:23 PMLiberty All-Star Growth Fund reports NAV of $5.56 as of August endseekingalpha.com - September 17 at 5:37 PMLiberty All-Star Equity Fund reports August NAV of $6.39seekingalpha.com - September 15 at 4:41 PMLiberty All-Star® Growth Fund, Inc. August 2023 Monthly Updatefinance.yahoo.com - September 15 at 4:41 PMNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop Headlines3 Stocks With Unusual Call Option ActivityMarch 26, 2024 1:10 PMView 3 Stocks With Unusual Call Option ActivityHigher Oil Prices Could Give NextEra’s Stock Earnings a BoostApril 24, 2024 10:40 AMView Higher Oil Prices Could Give NextEra’s Stock Earnings a Boost3M Spun Off Its Health Division, Is It Still A Buy?April 4, 2024 7:47 AMView 3M Spun Off Its Health Division, Is It Still A Buy?4 Dividend Aristocrats Trading at a DiscountApril 1, 2024 6:10 AMView 4 Dividend Aristocrats Trading at a DiscountCan Altimmune get its GLP-1 Drug to Market Before Cash Rush Out? April 9, 2024 6:07 AMView Can Altimmune get its GLP-1 Drug to Market Before Cash Rush Out? All Headlines Company DescriptionsAltimmuneNASDAQ:ALTAltimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide, a GLP-1/glucagon dual receptor agonist that is in Phase 2 trial for the treatment of obesity and metabolic dysfunction-associated steatohepatitis. It is also developing HepTcell, an immunotherapeutic product candidate, which is in Phase 2 clinical trial for patients chronically infected with the hepatitis B virus. The company was formerly known as Vaxin Inc. and changed its name to Altimmune, Inc. in September 2015. Altimmune, Inc. was founded in 1997 is headquartered in Gaithersburg, Maryland.Liberty All-Star Growth FundNYSE:ASGLiberty All-Star Growth Fund, Inc. is a closed-ended equity mutual fund launched and managed by ALPS Advisers, Inc. It is co-managed by Weatherbie Capital, LLC, Congress Asset Management Company, and Sustainable Growth Advisers, LP. The fund invests in the public equity markets of the United States. It seeks to invest in stocks of companies operating across diversified sectors. The fund primarily invests in growth stocks of companies across all market capitalizations. It employs fundamental analysis with a bottom-up stock picking approach to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Composite Index, Russell 3000 Growth Index, and the S&P 500 Index. It conducts in-house research to make its investments. The fund was previously known as Charles Allmon Trust, Inc. Liberty All-Star Growth Fund, Inc. was formed on March 14, 1986 and is domiciled in the United States. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.